SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,255 | +4.0% | 1,553 | -1.8% | 0.14% | +8.3% |
| Q2 2023 | $181,056 | -16.9% | 1,581 | 0.0% | 0.13% | -20.0% |
| Q1 2023 | $217,909 | +0.2% | 1,581 | -5.8% | 0.16% | -4.1% |
| Q4 2022 | $217,435 | +17.5% | 1,678 | 0.0% | 0.17% | +12.4% |
| Q3 2022 | $185,000 | +302.2% | 1,678 | +170.6% | 0.15% | +325.0% |
| Q2 2022 | $46,000 | +2200.0% | 620 | +1966.7% | 0.04% | +3500.0% |
| Q1 2022 | $2,000 | -98.6% | 30 | -98.2% | 0.00% | -98.9% |
| Q4 2021 | $148,000 | – | 1,645 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |